Pursuant to Regulation 30 Read with Schedule III of the SEBI(Listing Obligations and Disclosure Requirnments ) Regulations 2015, we hereby inform you about the change in Senior Manaaement personnel of the Company.
Jenburkt Pharmaceuticals Ltd Press Release Sep 04 2026
Filed with BSE · · 3 pages · English
Release
Jenburkt Pharmaceuticals Ltd on 6ix
Earlier from Jenburkt Pharmaceuticals
- Jenburkt Pharmaceuticals Ltd Press Release Aug 07 2026
- Jenburkt Pharmaceuticals Ltd Press Release Aug 04 2026
- Jenburkt Pharmaceuticals Ltd Press Release Aug 03 2026
- Jenburkt Pharmaceuticals Ltd Press Release Jul 29 2026
- Jenburkt Pharmaceuticals Ltd Press Release Jul 13 2026
Later from Jenburkt Pharmaceuticals
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals